PMID: 7019725Jul 30, 1981Paper

Actions of cholera toxin and the prevention and treatment of cholera

Nature
J Holmgren

Abstract

The drastic intestinal secretion of fluid and electrolytes that is characteristic of cholera is the result of reasonably well understood cellular and biochemical actions of the toxin secreted by Vibrio cholerae. Based on this understanding it is possible to devise new techniques for the treatment and prophylaxis of cholera to complement those based on fluid replacement therapy and sanitation.

References

Mar 23, 1976·Biochemistry·D M Gill
Jan 1, 1977·Annual Review of Biochemistry·A M Pappenheimer
Oct 13, 1977·Nature·J HolmgrenH Lundbeck
Feb 24, 1979·Lancet·G H RabbaniI Lönnroth
Jun 1, 1979·Infection and Immunity·J W PetersonA Kurosky
Apr 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·T Honda, R A Finkelstein
Jan 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·V BennettP Cuatrecasaş
Mar 1, 1976·The Journal of Infectious Diseases·J Holmgren, I Lönnroth
Apr 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·J MossR O Brady
May 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·B R MullinR O Brady
Dec 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·J MossM Vaughan
Aug 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·D Cassel, Z Selinger
May 1, 1978·The Journal of Clinical Investigation·N TurjmanT R Hendrix
Jun 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D Cassel, T Pfeuffer
Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D M Gill, R Meren
Sep 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·H A HanssonL Svennerholm
Nov 1, 1977·Journal of Clinical Microbiology·R H YolkenA Z Kapikian
Jun 1, 1979·Infection and Immunity·I LönnrothJ Holmgren
Feb 1, 1979·European Journal of Biochemistry·M TomasiG D'Agnolo
Jun 1, 1979·The Journal of Infectious Diseases·D M Gill, R S Rappaport
Jan 1, 1975·Journal of General Microbiology·J Holmgren, I Lonnroth
Sep 1, 1975·European Journal of Biochemistry·J Sattler, H Wiegandt
Mar 1, 1976·The Journal of Infectious Diseases·C Y LaiD Chang
Mar 1, 1976·The Journal of Infectious Diseases·N OhtomoK Amako
Feb 1, 1977·Hoppe-Seyler's Zeitschrift für physiologische Chemie·J SattlerH Wiegandt
Sep 23, 1977·Science·P B SiglerR A Finkelstein
Oct 1, 1976·Journal of Neurocytology·L Manuelidis, E E Manuelidis
Jul 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·J HolmgrenL Svennerholm
Oct 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·S W Craig, P Cuatrecasas
Jan 1, 1975·Annual Review of Microbiology·R B Sack
Nov 1, 1975·The Journal of Clinical Investigation·J Flores, G W Sharp
Aug 17, 1968·Lancet·D R NalinR A Phillips
Jun 1, 1973·Journal of General Microbiology·I Lönnroth, J Holmgren
Feb 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·J Wolff, A B Jones
May 1, 1970·The Journal of Infectious Diseases·W B GreenoughM Vaughan
Jan 22, 1971·Nature·G W Sharp, S Hynie

❮ Previous
Next ❯

Citations

Dec 14, 2004·European Journal of Immunology·Tania K UrenRichard A Strugnell
Apr 1, 1995·The Histochemical Journal·S Kudo, S Yazawa
Jan 1, 1995·Cancer Chemotherapy and Pharmacology·J M ReidM M Ames
Jan 1, 1982·The Journal of Membrane Biology·P H Fishman
Jan 1, 1995·Transactions of the Royal Society of Tropical Medicine and Hygiene·W A KhanD Mahalanabis
Jan 1, 1982·Toxicon : Official Journal of the International Society on Toxinology·J E Alouf
Jan 1, 1990·Toxicon : Official Journal of the International Society on Toxinology·G MenestrinaC A Pasternak
Jan 1, 1985·Pharmacology & Therapeutics·R A Finkelstein, F Dorner
May 1, 1984·Veterinary Immunology and Immunopathology·T J Newby, C R Stokes
Apr 29, 1982·Biochimica Et Biophysica Acta·J Hagmann, P H Fishman
Oct 9, 1989·Biochimica Et Biophysica Acta·A PessinaC E Cocuzza
Apr 1, 1989·Vaccine·J HolmgrenA M Svennerholm
Jan 1, 1992·Vaccine·J HolmgrenH Wigzell
Apr 26, 1982·Neuroscience Letters·S R FordaC A Pasternak
Oct 1, 1992·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·S CollinsM Howden
Sep 1, 1990·Research in Microbiology·N F FairweatherG Dougan
Sep 1, 1990·Research in Microbiology·J SanchezJ Holmgren
Jan 1, 1988·Baillière's Clinical Gastroenterology·O Lundgren

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
J Sanchez, J Holmgren
Proceedings of the National Academy of Sciences of the United States of America
S J HardyT R Hirst
The Journal of Infectious Diseases
S T DontaN J Poindexter
Biochemical and Biophysical Research Communications
L K Duffy, C Y Lai
© 2021 Meta ULC. All rights reserved